Explore
13D/13G Activist Filings
119,179 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | N/A | NightFood Holdings, Inc. | EAGLE EQUITIES LLC | 13G | 8.0% | 12.5M |
| Nov 18, 2025 | BRR | Columbus Circle Capital Corp. I | Glazer Capital, LLC | 13D | 7.7% | 2.0M |
| Nov 18, 2025 | N/A | Fidelity Multi-Strategy Credit Fund | FMR LLC | 13D/A | 56.2% | 2.9M |
| Nov 18, 2025 | HMR | Heidmar Maritime Holdings Corp. | Rhea Marine Ltd. | 13D/A | 44.9% | 26.2M |
| Nov 18, 2025 | DCOY | Salarius Pharmaceuticals, Inc. | CVI Investments, Inc. | 13G | 9.9% | 362K |
| Nov 18, 2025 | OSS | ONE STOP SYSTEMS, INC. | Lynrock Lake LP | 13G/A | 6.6% | 1.4M |
| Nov 18, 2025 | UEIC | UNIVERSAL ELECTRONICS INC | Kent Lake PR LLC | 13G/A | 4.9% | 667K |
| Nov 18, 2025 | ZONE | CleanCore Solutions, Inc. | MMCAP International Inc. SPC | 13G | 5.5% | 12.2M |
| Nov 18, 2025 | NEUP | Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP | 13D/A | 16.3% | 875K |
| Nov 18, 2025 | SUPX | SuperX AI Technology Ltd | Mirae Asset Securities (HK) Ltd | 13G | 8.3% | 3.3M |
| Nov 18, 2025 | HEPS | D-MARKET Electronic Services & Trading | Joint Stock Company Kaspi.kz | 13D/A | 69.5% | 223.2M |
| Nov 18, 2025 | CMND | Clearmind Medicine Inc. | Iroquois Capital Management, LLC | 13G/A | 5.4% | 311K |
| Nov 18, 2025 | FIGR | Figure Technology Solutions, Inc. | DCM Opportunity Fund III, L.P. | 13G | 0.1% | 201K |
| Nov 18, 2025 | BLND | Blend Labs, Inc. | Haveli Brooks Aggregator, L.P. | 13D/A | 20.8% | 65.4M |
| Nov 18, 2025 | GLTO | Galecto, Inc. | Fairmount Funds Management LLC | 13D | 20.0% | 397K |
| Nov 18, 2025 | CNTA | Centessa Pharmaceuticals plc | General Atlantic Cooperatief U.A. | 13D/A | 6.6% | 9.7M |
| Nov 18, 2025 | ORIC | ORIC Pharmaceuticals, Inc. | The Column Group II, LP | 13G/A | 3.6% | 3.5M |
| Nov 18, 2025 | HOWL | WEREWOLF THERAPEUTICS, INC. | MPM BioVentures 2014, L.P. | 13D/A | 4.9% | 2.4M |
| Nov 18, 2025 | CSIQ | Canadian Solar Inc. | Venture Holding S.a.r.l. SPF | 13G/A | 9.0% | 6.0M |
| Nov 18, 2025 | APRE | Aprea Therapeutics, Inc. | LYTTON LAURENCE W | 13G | 9.9% | 682K |
| Nov 18, 2025 | NN | NextNav Inc. | Joseph D. Samberg | 13G/A | 9.9% | 13.4M |
| Nov 18, 2025 | CLNE | CLEAN ENERGY FUELS CORP. | TotalEnergies SE | 13D/A | 23.3% | 51.1M |
| Nov 17, 2025 | TIPT | TIPTREE INC. | Veradace Capital Management LLC | 13D/A | 5.1% | 1.9M |
| Nov 17, 2025 | VVX | V2X, Inc. | American Industrial Partners Capital Fund VI, L.P. | 13D/A | 18.7% | 5.8M |
| Nov 17, 2025 | BJRI | BJ's Restaurants, Inc. | BJ's Act III, LLC | 13D/A | 5.7% | 1.3M |
| Nov 17, 2025 | CORZ | Core Scientific, Inc. | Two Seas Capital LP | 13D/A | 8.0% | 24.7M |
| Nov 17, 2025 | FOA | FINANCE OF AMERICA COMPANIES INC. | BTO Urban Holdings L.L.C. | 13D/A | 43.9% | 5.6M |
| Nov 17, 2025 | EVC | Entravision Communications Corporation | Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 13D/A | 13.4% | 11.0M |
| Nov 17, 2025 | NFGC | NEW FOUND GOLD CORP. | Sprott Eric | 13D/A | 19.4% | 65.9M |
| Nov 17, 2025 | UNF | UNIFIRST CORP | River Road Asset Management, LLC | 13D | 6.1% | 881K |
| Nov 17, 2025 | AMLX | Amylyx Pharmaceuticals, Inc. | Commodore Capital LP | 13G | 5.1% | 5.7M |
| Nov 17, 2025 | CEPT | Cantor Equity Partners II, Inc. | RichRich Capital LLC | 13G | 5.6% | 1.4M |
| Nov 17, 2025 | TRMD | TORM plc | OCM NJORD HOLDINGS S.A R.L. | 13D/A | 40.0% | 40.6M |
| Nov 17, 2025 | GSRFU | GSR IV Acquisition Corp. | GSR IV Sponsor LLC | 13G | 26.7% | 6.3M |
| Nov 17, 2025 | SMSI | SMITH MICRO SOFTWARE, INC. | SMITH WILLIAM W JR | 13D | 30.0% | 8.4M |
| Nov 17, 2025 | SATS | EchoStar Corporation | REDWOOD CAPITAL MANAGEMENT LLC | 13G/A | 3.6% | 5.6M |
| Nov 17, 2025 | DHT | DHT Holdings | BW Group Limited | 13D/A | 10.6% | 17.0M |
| Nov 17, 2025 | ALMS | ALUMIS INC. | Samsara BioCapital, L.P. | 13D/A | 4.6% | 4.5M |
| Nov 17, 2025 | EVMN | EVOMMUNE, INC. | RA Capital Management, L.P. | 13D | 11.0% | 3.5M |
| Nov 17, 2025 | CDTX | CIDARA THERAPEUTICS, INC. | RA Capital Management, L.P. | 13D/A | 10.7% | 3.4M |
| Nov 17, 2025 | COGT | Cogent Biosciences, Inc. | Fairmount Funds Management LLC | 13D/A | 9.9% | 15.9M |
| Nov 17, 2025 | EVMN | EVOMMUNE, INC. | Andera Partners | 13G | 6.0% | 1.9M |
| Nov 17, 2025 | MMTXU | Miluna Acquisition Corp | MilunaC Technology Limited | 13D | 20.9% | 1.8M |
| Nov 17, 2025 | ULY | Urgent.ly Inc. | Iron Gate Management LLC | 13G/A | 0.0% | 0 |
| Nov 17, 2025 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | 13G/A | 6.8% | 3.0M |
| Nov 17, 2025 | W | Wayfair Inc. | Steven Conine | 13G/A | 9.3% | 10.8M |
| Nov 17, 2025 | MRKR | Marker Therapeutics, Inc. | New Enterprise Associates 16, L.P. | 13D/A | 9.9% | 1.7M |
| Nov 17, 2025 | W | Wayfair Inc. | Niraj Shah | 13G/A | 9.3% | 10.8M |
| Nov 17, 2025 | SBLX | StableX Technologies, Inc. | Iroquois Capital Management, LLC | 13G/A | 10.0% | 148K |
| Nov 17, 2025 | PONY | Pony AI Inc. | Jun Peng | 13G/A | 13.8% | 60.0M |